Chong-Shin Clinic, New Taipei City, Taiwan.
Samuel Chen Clinic, Nantou County, Taiwan.
PeerJ. 2022 Jul 27;10:e13636. doi: 10.7717/peerj.13636. eCollection 2022.
To investigate the quality of care and prescription patterns of patients with diabetic kidney disease (DKD) receiving primary care at local clinics in Taiwan.
A retrospective chart review was conducted in 43 primary care clinics in Taiwan. The patients' baseline characteristics, laboratory tests, presence of complications and antidiabetic agents prescribed were analyzed.
7,200 patients with type 2 diabetes mellitus were enrolled. Percentage of HbA1c, blood pressure (BP), and low density lipoprotein cholesterol (LDL-C) goals reached were 52.5% in HbA1c < 7%, 40.9% in BP < 130/80 mmHg and 79.7% in LDL-C < 2.59 mmol/L. 18.3% achieved all three ABC goals. However, patients with DKD had a lower rate of ABC goal attainment and higher rate of complications. Among DKD patients with eGFR ≥ 30 ml/min/1.73 m and on monotherapy, metformin was most frequently prescribed. As for dual therapy, the most common combinations were metformin with sulfonylurea and metformin with DPP-4 inhibitors.
Diabetes patients in Taiwan receiving primary diabetes care at local clinics had generally satisfactory management performance. However, more aggressive HbA1c, BP, and LDL-C management among DKD patients should be emphasized. Contrary to current recommendations, SGLT-2 inhibitors and GLP-1 receptor agonists as frontline therapy were under-prescribed.
调查在台湾当地诊所接受初级保健的糖尿病肾病(DKD)患者的护理质量和处方模式。
对台湾 43 家初级保健诊所进行了回顾性病历审查。分析了患者的基线特征、实验室检查、并发症的存在情况以及开具的降糖药物。
共纳入 7200 例 2 型糖尿病患者。HbA1c<7%、血压(BP)<130/80mmHg 和 LDL-C<2.59mmol/L 的达标率分别为 52.5%、40.9%和 79.7%。18.3%的患者达到了 ABC 三个目标。然而,DKD 患者达到 ABC 目标的比例较低,并发症发生率较高。在 eGFR≥30ml/min/1.73m2 且接受单药治疗的 DKD 患者中,最常开具的药物是二甲双胍。对于联合治疗,最常见的组合是二甲双胍与磺脲类药物和二甲双胍与 DPP-4 抑制剂。
在台湾当地诊所接受初级糖尿病护理的糖尿病患者的管理表现总体上令人满意。然而,应该更加重视 DKD 患者的 HbA1c、BP 和 LDL-C 管理。与当前的建议相反,SGLT-2 抑制剂和 GLP-1 受体激动剂作为一线治疗药物的处方不足。